Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2012
07/19/2012US20120185954 Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression
07/19/2012US20120184720 Process for removing organic solvents from a biomass
07/19/2012US20120184715 Eluate Collection Using Conductivity Gradient
07/19/2012US20120184713 Compositions and Methods for Modulation of Bone Density and Biomineralization
07/19/2012US20120184712 Homogenous populations of molecules
07/19/2012US20120184711 Novel polypeptide, an affinity chromatography material, and a method for separating and/or purifying immunoglobulin
07/19/2012US20120184710 Borrelia antigens
07/19/2012US20120184498 Dermaseptin b2 used as an inhibitor of the growth of a tumor
07/19/2012US20120184492 Therapeutic use of a growth factor, nsg33
07/19/2012US20120184489 Prodrugs comprising an insulin linker conjugate
07/19/2012US20120184488 Insulin analogues of enhanced receptor-binding specificity
07/19/2012US20120184487 Insulin derivatives
07/19/2012US20120184482 Novel Ubiquitin-Isopeptide Probes
07/19/2012US20120184481 Variants of pigment epithelium derived factor and uses thereof
07/19/2012US20120184459 Taste Receptors Of The T1R Family From Domestic Cat
07/19/2012US20120183999 Use of multiple recombination sites with unique specificity in combinational cloning
07/19/2012US20120183995 Enhanced protein expression in bacillus
07/19/2012US20120183988 Intein-based fluorescent bio-circuit for vitamin d detection
07/19/2012US20120183979 Protein fragments of virb10 and sero-detection of anaplasma phagocytophilum
07/19/2012US20120183975 Taste Receptors Of The T1R Family From Domestic Dog
07/19/2012US20120183964 Mammalian cytokine; related reagents
07/19/2012US20120183601 Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha
07/19/2012US20120183599 Pharmaceutical Composition
07/19/2012US20120183570 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions
07/19/2012US20120183569 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
07/19/2012US20120183562 Secreted fxyd proteins expressed in response to epithelial tissue damage, and uses therefor
07/19/2012US20120183554 Biomarker
07/19/2012US20120183553 Treatment and diagnosis of immune disorders
07/19/2012US20120183552 Kidney disease targets and uses thereof
07/19/2012US20120183551 Novel human p53 splice variant displaying differential transcriptional activity
07/19/2012US20120183532 Compounds stimulating undesirable cellular adhesion and applications thereof
07/19/2012US20120183495 Avian colony stimulating factor 1 receptor binding proteins
07/19/2012CA2824752A1 Bcl-2-like protein 11 srm/mrm assay
07/19/2012CA2824235A1 Novel wnt compositions and therapeutic uses of such compositions
07/19/2012CA2822693A1 Radiolabled her2 binding peptides
07/18/2012EP2476753A1 Construct coated with virus coat-constituting protein and method for producing same
07/18/2012EP2476701A1 Antimicrobial agents based on hemin derivatives
07/18/2012EP2476700A1 Modified growth hormones
07/18/2012EP2476699A2 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
07/18/2012EP2476698A2 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
07/18/2012EP2476697A2 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
07/18/2012EP2476696A2 Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer
07/18/2012EP2476695A2 Peptide vaccines for cancers expressing tumor-associated antigens
07/18/2012EP2476694A2 Peptide vaccines for cancers expressing tumor-associated antigens
07/18/2012EP2476693A2 Peptide vaccines for cancers expressing tumor-associated antigens
07/18/2012EP2476692A2 Peptide vaccines for cancers expressing tumor-associated antigens
07/18/2012EP2476440A1 Therapeutic compositions for the treatment of hpv-induced diseases
07/18/2012EP2476437A2 Immunogenic peptides and their use in immune disorders
07/18/2012EP2476436A2 Immunogenic peptides and their use in immune disorders
07/18/2012EP2476435A2 Immunogenic peptides and their use in immune disorders
07/18/2012EP2476431A1 Lyophilised antigen composition
07/18/2012EP2475681A1 Plgf-1 in homodimeric form
07/18/2012EP2475680A1 Molecules capable of inducing cell death by targeting the mitochondria and applications thereof
07/18/2012EP2475679A1 Improved optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production
07/18/2012EP2475427A1 Actriib antagonists and dosing and uses thereof
07/18/2012EP2475398A1 Improved pseudomonas exotoxin a with reduced immunogenicity
07/18/2012EP2475397A1 Use of interleukin-1 beta mutein conjugates in the treatment of diabetes
07/18/2012EP2475386A1 Hypoallergenic hybrid polypeptides for the treatment of allergy
07/18/2012EP2475385A1 Combination vaccines against respiratory tract diseases
07/18/2012EP2399993A9 Hypo-immunogenic streptavidin and use thereof
07/18/2012EP2183274B1 Methods and compositions for targeting proteins of interest to the host cell envelope
07/18/2012EP2132222B1 Anti diabetic protein
07/18/2012EP2086576B1 H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
07/18/2012EP2061807B1 MHC oligomers, components thereof, and methods of making the same
07/18/2012EP1869086B1 Methods and compositions for modulating and detecting wisp activity
07/18/2012EP1856144B1 Method for the redox potential-dependent detection of target molecules by interactive peptides
07/18/2012EP1840082B1 Nanographite structure/metal nanoparticle composite
07/18/2012EP1786832B1 Transport protein which is used to introduce chemical compounds into nerve cells
07/18/2012EP1771569B1 Methods and compositions for modulating flowering and maturity in plants
07/18/2012EP1437961B1 Methods of suppressing microglial activation
07/18/2012EP1435999B1 Combination of two bioactive regions of pro-opiomelanocortin hormone
07/18/2012EP1183345B1 Directed evolution of microorganisms
07/18/2012EP0906577B2 Screening compounds for the ability to alter the production of amyloid-beta peptide
07/18/2012CN1839202B Process for producing cytotoxic lymphocytes
07/18/2012CN1780553B Generation of plants with altered oil content
07/18/2012CN1774448B Growth factor complexes and modulation of cell migration and growth
07/18/2012CN1449445B Ev-vegf nucleic acids and polypeptides and methods of use
07/18/2012CN102597240A A fungal serine protease and use thereof
07/18/2012CN102597238A Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2
07/18/2012CN102597224A Methods for improving malic acid production in filamentous fungi
07/18/2012CN102597006A Fusion polypeptides and uses thereof
07/18/2012CN102597000A Glycosylated repeat-motif-molecule conjugates
07/18/2012CN102596998A Treatment of vasculoproliferative conditions
07/18/2012CN102596993A Multimeric peptide conjugates and uses thereof
07/18/2012CN102596992A Fibronectin type III domain based scaffold compositions, methods and uses
07/18/2012CN102596991A Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor
07/18/2012CN102596990A PLGF-1 in homodimeric form
07/18/2012CN102596989A Induced derivation of specific endoderm from hps cell-derived definitive endoderm
07/18/2012CN102596988A Insecticidal proteins
07/18/2012CN102596244A 丙型肝炎病毒疫苗组合物 HCV vaccine composition
07/18/2012CN102596240A Hybrid polypeptides including meningococcal fHBP sequences
07/18/2012CN102596236A Antigenic Tau peptides and uses thereof
07/18/2012CN102596234A Dendritic cell vaccines for asparaginyl-beta-hydroxylase expressing tumors
07/18/2012CN102596230A Quantitation of insulin-like growth factor-i and insulin-like growth factor-ii with high-resolution mass spectrometry
07/18/2012CN102596228A Neuropeptide-2 receptor (Y-2R) agonists
07/18/2012CN102596223A Tumoricidal, bactericidal, or viricidal macrophage activation
07/18/2012CN102596221A Immunological targeting of pathological TAU proteins
07/18/2012CN102596175A Aqueous insulin preparations containing methionine
07/18/2012CN102590530A Application of KRT84 self-immune antibody as diagnosis marker for diagnosing and detecting rheumatoid arthritis
07/18/2012CN102590504A CoxB IgG/Ig/M test kit using enzyme linked immunosorbent assay
1 ... 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 ... 2916